Jung Kwan Jang showcases scientific evidence on red ginseng’s efficacy and safety at US botanical conference

Jung Kwan Jang recently hosted a red ginseng academic seminar titled “Efficacy and Safety of Red Ginseng” during the International Conference on the Science of Botanicals (ICSB), held at the Oxford Conference Center in Mississippi. The event was organized by the U.S. National Center for Natural Products Research (NCNPR).

More than 400 attendees, including representatives from the U.S. (FDA), Department of Agriculture (USDA), National Science Foundation (NSF), National Institutes of Health (NIH), and leading university researchers, gathered to hear about the latest scientific evidence supporting red ginseng’s health benefits.

Researchers from both Korea and the U.S. presented findings validating red ginseng’s positive effects on cardiovascular health, immune cell anti-aging, and overall safety.

Red ginseng has been officially recognized by the Ministry of Food and Drug Safety (MFDS) for seven functional claims -- enhancing immunity, improving blood flow through platelet aggregation inhibition, reducing fatigue, providing antioxidant effects, improving memory, supporting menopausal health, and regulating blood sugar.

During the seminar, Dr. Amir Rafie, a vascular specialist at Valiance Clinical Research, shared clinical trial results conducted in the U.S. involving 108 healthy adults.

Participants were divided into placebo and red ginseng groups (480 mg and 2,000 mg daily) over a 12-week period. The study found that platelet aggregation decreased by 10 percent and 16 percent in the ginseng groups, respectively, compared to the placebo, while no significant changes were observed in coagulation markers—suggesting safe inhibition of blood clot formation.

Professor Song Min-ho from KAIST Graduate School of Medical Science and Engineering also presented data showing that red ginseng extract enhances mitochondrial activity in aging immune cells, reduces inflammation-related substances, and helps prevent immune cell aging—highlighting its potential to support immune function as people age.

“While red ginseng is already known as a beneficial health product, this seminar was particularly meaningful in presenting research conducted not only in Korea but also in the U.S. on cardiovascular health, immune support, and anti-aging,” NCNPR Director Dr. Ikhlas Khan said.

Jung Kwan Jang U.S. R&D Center Head Lee Yoon-beom also said, “Red ginseng is gluten-free, caffeine-free, and aligned with global health trends.”

With over 1,200 peer-reviewed scientific publications, the company will continue raise awareness among U.S. consumers about the scientifically validated benefits of red ginseng, Lee added.

Lee also unveiled the company’s plan to expand collaborative research with U.S. universities and hospitals to further globalize K-Ginseng as Korea’s leading health ingredient